3-Amino-4-Bromopyridine: A Closer Look From the Manufacturer’s Bench

An Introduction Rooted in Real Production Experience

Our team handles 3-Amino-4-Bromopyridine daily, working hands-on with its synthesis, purification, and packaging. Its CAS number is 13020-13-4, and we produce it in bulk and smaller laboratory-scale batches to meet the needs of both commercial and research customers. This specialty heterocyclic intermediate is a solid crystalline compound with a characteristic off-white to pale beige appearance. The molecular formula is C₅H₅BrN₂, and it has a molecular weight of about 173.01 g/mol.

3-Amino-4-Bromopyridine stands out for its balanced combination of reactivity and selectivity. The amino group at position 3 lends nucleophilic properties, while the bromine at position 4 opens up multiple cross-coupling possibilities. These two features, merged in a single pyridine ring, create opportunities for building complex structures efficiently. From the manufacturer’s vantage, this molecular architecture justifies its consistent demand in pharmaceutical research and industrial synthesis.

Why Chemists Keep Requesting This Molecule

We see a steady stream of orders from process chemists and discovery teams. The reasons are clear when a closer look is taken at the molecule’s behavior during both large-scale and bench-scale transformations. The combination of an amino functionality and a halogenated aromatic ring supplies two reactive handles, allowing for palladium-catalyzed coupling, nucleophilic substitution, and directed metalation.

Each batch goes through routine TLC, HPLC, and NMR quality assessment for purity, typically reaching levels above 98%. Our batches run clean, reducing troubleshooting down the line. This assurance is possible because our plant relies on well-established routes and robust purification—key to meeting regulatory and analytical standards for both GMP and non-GMP applications.

Applications That Rely on Consistency and Purity

In our experience, 3-Amino-4-Bromopyridine finds its primary home in drug discovery. It serves as a backbone in developing kinase inhibitors, anti-inflammatory agents, and even certain antiviral scaffolds. The demand for fine-tuning small-molecule drug properties has increased requests for intermediates like this, as medicinal chemists look for building blocks that can handle diverse modifications.

We also receive inquiries from manufacturers of agrochemicals and electronic materials. Here, the molecule supports the creation of specialty ligands, dyes, and other functionalized pyridine derivatives where both amino and bromo groups play a critical role. Its ability to respond reliably in Suzuki-Miyaura, Buchwald-Hartwig, and similar palladium-catalyzed reactions is a recurring reason for selection.

Scale-up consistency matters—the transition from gram- to kilogram-scale often strains less robust intermediates, but our reactors and purification columns run smoothly up to pilot plant volumes. Our production crews routinely manage kilograms-per-month orders with tight batch-to-batch tracking, supporting projects that can’t tolerate surprises in reactivity or impurity profiles.

What Sets It Apart from Other Substituted Pyridines

Chemists often ask about differences between 3-Amino-4-Bromopyridine and related compounds like 4-Amino-3-Bromopyridine, 3-Amino-5-Bromopyridine, or 3-Amino-4-Chloropyridine. The substitution pattern determines regiochemistry in downstream reactions. In the 3-amino-4-bromo arrangement, we find greater flexibility for orthogonal transformations—one group can be protected or transformed while leaving the other available. This simplicity improves step economy, critical for time-sensitive projects.

Our experience shows a sharper reaction profile for the 4-bromo position compared to typical chloro-substituted analogs. The heavier bromine atom is more reactive in cross-coupling, which cuts down on catalyst load and sometimes gives higher yields. The amino group’s position supports directed ortho-metalation, opening routes unavailable from other isomers.

Other manufacturers sometimes offer broader pyridine mixes, but our focused process on this specific isomer means less isomeric contamination. This speaks directly to teams who need clean product for structure-activity studies. Requesting the correct isomer can mean skipping months of purification steps, or even rescuing a stalled project.

Challenges We’ve Overcome, and What Still Needs Attention

More than once, we’ve been asked about potential nitrosamine formation or trace metal content. Compliance with evolving global guidelines is never just a paperwork exercise. Our facility responds with regular audits and validation runs, exploiting in-house analytics to spot even low-level impurities. When customers share their regulatory filings with us, our data supports them when precise impurity profiles are needed. We keep full documentation for every lot, often backing up claims with both in-house and third-party lab results.

Other companies have struggled to maintain low moisture content in hygroscopic heterocycles. Over years of production, we’ve installed enhanced drying units and switched to triple-sealed packaging. The result: moisture content stays below threshold, shipment after shipment, across climates. This extends shelf life and reduces waste on the user’s side.

Worker safety also calls for constant attention. From raw material handling to spent solvent management, our staff follows clear protocols—double-glove use, explosion-proof equipment, and regular exposure monitoring. Rather than waiting for new regulations, we invest in controls so that our site remains ahead of global health and environmental standards. Customers gain confidence, knowing that we deliver not only high-purity but also safer materials.

Tackling Supply Chain Volatility

The past few years shook up global raw material supplies. Many buyers remember sudden price spikes or delays caused by a shortage of brominated starting materials. Our response focused on keeping a deeper buffer stock of essential precursors and building strong relationships with primary producers. These partnerships shield customers from upstream disruptions as much as possible. We also invested in secondary synthesis routes and diversified purchasing to minimize shutdowns from any one supplier or region.

Some buyers reach out when a prior supplier exits the market or shifts priorities. We absorb these demands—which can run into the hundreds of kilos at short notice—by expanding reaction vessel capacity and retraining staff for flexible crew scheduling. Customers have remarked that they can depend on us, even when others cannot ramp up quickly enough to avoid project delays.

Collaborating with Customers, Not Just Selling a Molecule

Experience tells us that the best results come from ongoing conversations. Instead of just shipping out a box, our technical support chemists review order history and check in about upcoming batch requirements. Customers sometimes seek custom impurity profiles or specifications on particle size. By providing pre-shipment samples and open access to analytical data, we make it easier for research and manufacturing teams to plan their work around what they will receive.

Sometimes a project encounters a bottleneck downstream—an unexpected intermediate incompatibility or solubility problem. Our process team often assists these troubleshooting sessions, using data pulled from our own production and QC archives. In some cases, we have even delivered custom grades of 3-Amino-4-Bromopyridine, adjusting drying times, sieve mesh, or solvent content as needed. These tweaks can save weeks of rework at the user’s site.

For customers developing new molecules or regulatory filings, traceability means peace of mind. Every batch can be traced to raw material lots, synthesis dates, and lab records, which we archive for years. Reliable service builds trust, repeat orders, and makes our molecule a preferred starting point across the industry.

Continuous Improvement from Factory Floor to End Product

Feedback cycles run tight in chemical manufacturing. We take the time to listen to complaints about clumping, off-colors, or slow dissolution—each issue tracked and triggers a response that often improves the product for all users. Over time, this cycle has led to incremental but meaningful changes in reactor design, solvent choices, and even packaging materials.

We also test for emerging impurities, responding to regulatory concerns, not only pharmaceutical customers but also electronics specialists and agrochemical formulation teams. Markets change quickly, so having a flexible, knowledgeable crew who can interpret the data and take direct action shapes the way our products meet today’s—and tomorrow’s—quality expectations.

Environmental Responsibility: From Effluent to Energy Use

Producing halogenated pyridines brings environmental obligations. From controlling brominated waste streams to minimizing solvent loss, our factory continually updates its processes. By recycling solvents, capturing and neutralizing off-gases, and investing in energy-efficient equipment, we bring down both operating costs and our environmental footprint. This is not just a marketing claim—it comes from years of strict compliance with local and international regulations.

Specific challenges include managing brominated organic waste and reducing water consumption. Our site operates a closed-loop water system, and product development teams routinely trial greener synthesis routes. Advances in catalysis have trimmed reaction times and lowered the need for excess reagents, so we use less and waste less at each stage. Every improvement here not only reduces costs but also improves public perception and regulatory ease for our clients.

Customers sometimes ask about the carbon footprint or sustainability data. We offer details on energy use, water consumption, and percentage of solvents recycled. Some clients now make supplier selection based on these numbers, reflecting the growing industry push for sustainable chemistry.

What the Future Holds for 3-Amino-4-Bromopyridine Users

Looking ahead, we see 3-Amino-4-Bromopyridine continuing to play a vital role in small molecule innovation. Its structural versatility and proven performance make it a reliable choice as chemical projects become more complex. More robust data-sharing between manufacturer and customer enables faster troubleshooting and more efficient project delivery, cutting time to market in industries where days or weeks make a difference.

Investments in greener chemistry, enhanced analytic capability, and greater production flexibility will help maintain a ready supply of this and related pyridines. New applications, especially in the rapidly growing areas of advanced materials and digital health technologies, keep demand high and motivate ongoing process improvements.

As experienced manufacturers, we recognize that every kilogram of 3-Amino-4-Bromopyridine shipped out carries both an opportunity and a responsibility. The right molecular building blocks form the cornerstone for innovation across many fields. By focusing on quality, traceability, and customer dialogue, we ensure that our material supports those breakthroughs, batch after batch and project after project.

Final Thoughts from the Production Team

Every week brings a blend of familiar routines and unexpected challenges. Our crew, from the operators on the reactor floor to the formulation scientists and logistics staff, all play a role in delivering a product that stands up to scrutiny. Our understanding of 3-Amino-4-Bromopyridine comes from time spent in the plant, troubleshooting unexpected test results, and responding daily to real customer concerns.

We work to keep standards high—not only because regulators demand it but because every bottle influences someone’s experiment, production run, or finished drug candidate. Quality here means more than a certificate; it’s a reflection of everything we’ve learned through direct, hands-on experience. Customers return, not for a name, but for the proven consistency our team delivers. No matter how the industry landscape changes, that’s a commitment we keep.